ArticleOncology research2026

Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented Conditions.

Chanwoong Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.